| High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability AK Croker, D Goodale, J Chu, C Postenka, BD Hedley, DA Hess, AL Allan Journal of cellular and molecular medicine 13 (8b), 2236-2252, 2009 | 656 | 2009 |
| The role of human aldehyde dehydrogenase in normal and cancer stem cells I Ma, AL Allan Stem cell reviews and reports 7, 292-306, 2011 | 614 | 2011 |
| Cancer stem cells: implications for the progression and treatment of metastatic disease AK Croker, AL Allan Journal of cellular and molecular medicine 12 (2), 374-390, 2008 | 378 | 2008 |
| Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells AK Croker, AL Allan Breast cancer research and treatment 133, 75-87, 2012 | 377 | 2012 |
| Circulating tumor cell analysis: technical and statistical considerations for application to the clinic AL Allan, M Keeney Journal of oncology 2010, 2010 | 238 | 2010 |
| Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis AL Allan, SA Vantyghem, AB Tuck, AF Chambers Breast disease 26 (1), 87-98, 2007 | 226 | 2007 |
| Assessment of the validity of nuclear-localized androgen receptor splice variant 7 in circulating tumor cells as a predictive biomarker for castration-resistant prostate cancer HI Scher, RP Graf, NA Schreiber, A Jayaram, E Winquist, B McLaughlin, ... JAMA oncology 4 (9), 1179-1186, 2018 | 219 | 2018 |
| Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial DA Palma, R Olson, S Harrow, RJM Correa, F Schneiders, CJA Haasbeek, ... BMC cancer 19, 1-15, 2019 | 191 | 2019 |
| Molecular mechanisms of breast cancer metastasis to the lung: clinical and experimental perspectives B Medeiros, AL Allan International journal of molecular sciences 20 (9), 2272, 2019 | 180 | 2019 |
| Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer PM McGowan, C Simedrea, EJ Ribot, PJ Foster, D Palmieri, PS Steeg, ... Molecular Cancer Research 9 (7), 834-844, 2011 | 164 | 2011 |
| Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management AB Tuck, AF Chambers, AL Allan Journal of cellular biochemistry 102 (4), 859-868, 2007 | 160 | 2007 |
| Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer AL Allan, R George, SA Vantyghem, MW Lee, NC Hodgson, CJ Engel, ... The American journal of pathology 169 (1), 233-246, 2006 | 158 | 2006 |
| β3 Integrin Expression Increases Breast Carcinoma Cell Responsiveness to the Malignancy-Enhancing Effects of Osteopontin KA Furger, AL Allan, SM Wilson, C Hota, SA Vantyghem, CO Postenka, ... Molecular cancer research 1 (11), 810-819, 2003 | 157 | 2003 |
| Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors M Rodriguez-Torres, AL Allan Clinical & experimental metastasis 33, 97-113, 2016 | 156 | 2016 |
| Nanoparticle‐mediated binning and profiling of heterogeneous circulating tumor cell subpopulations RM Mohamadi, JD Besant, A Mepham, B Green, L Mahmoudian, T Gibbs, ... Angewandte Chemie International Edition 54 (1), 139-143, 2015 | 155 | 2015 |
| Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer AL Allan, R George, SA Vantyghem, MW Lee, NC Hodgson, CJ Engel, ... The American journal of pathology 169 (1), 233-246, 2006 | 155 | 2006 |
| Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer SA Sabra, AO Elzoghby, SA Sheweita, M Haroun, MW Helmy, ... European Journal of Pharmaceutics and Biopharmaceutics 128, 156-169, 2018 | 135 | 2018 |
| Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system AC Nichols, LE Lowes, CCT Szeto, J Basmaji, S Dhaliwal, C Chapeskie, ... Head & neck 34 (10), 1440-1444, 2012 | 130 | 2012 |
| The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression BD Hedley, AL Allan, A Xenocostas Clinical cancer research 17 (20), 6373-6380, 2011 | 123 | 2011 |
| Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease I Plante, MKG Stewart, K Barr, AL Allan, DW Laird Oncogene 30 (14), 1681-1692, 2011 | 121 | 2011 |
Ann F. ChambersProfessor Emerita, Oncology, Medical Biophysics, Pathology & Lab. Med., Western Universityuwo.ca üzerinde doğrulanmış e-posta adresine sahip
